Annual report
7751.TEDINET S100XTLJ
Period2025-01-01 → 2025-12-31
Filed2026-03-25
StandardUS GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.62T | 2025-01-01 → 2025-12-31 | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥4.51T | 2024-01-01 → 2024-12-31 | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥4.18T | 2023-01-01 → 2023-12-31v | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥4.03T | 2022-01-01 → 2022-12-31v | Cons. | Revenues US GAAP (5-year summary) |
| Revenue | ¥3.51T | 2021-01-01 → 2021-12-31d | Cons. | Revenues US GAAP (5-year summary) |
| Profit before tax | ¥482.1bn | 2025-01-01 → 2025-12-31 | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥301.2bn | 2024-01-01 → 2024-12-31 | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥390.8bn | 2023-01-01 → 2023-12-31v | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥352.4bn | 2022-01-01 → 2022-12-31v | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Profit before tax | ¥302.7bn | 2021-01-01 → 2021-12-31d | Cons. | Profit loss before tax US GAAP (5-year summary) |
| Net income (owners) | ¥332.1bn | 2025-01-01 → 2025-12-31 | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥160.0bn | 2024-01-01 → 2024-12-31 | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥264.5bn | 2023-01-01 → 2023-12-31v | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥244.0bn | 2022-01-01 → 2022-12-31v | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Net income (owners) | ¥214.7bn | 2021-01-01 → 2021-12-31d | Cons. | Net income loss attributable to owners of parent US GAAP (5-year summary) |
| Total assets | ¥6.14T | at 2025-12-31 | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥5.77T | at 2024-12-31 | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥5.42T | at 2023-12-31v | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥5.10T | at 2022-12-31v | Cons. | Total assets US GAAP (5-year summary) |
| Total assets | ¥4.75T | at 2021-12-31d | Cons. | Total assets US GAAP (5-year summary) |
| Equity (owners) | ¥3.49T | at 2025-12-31 | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥3.38T | at 2024-12-31 | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥3.35T | at 2023-12-31v | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥3.11T | at 2022-12-31v | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Equity (owners) | ¥2.87T | at 2021-12-31d | Cons. | Equity attributable to owners of parent US GAAP (5-year summary) |
| Cash & equivalents | ¥586.0bn | at 2025-12-31 | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥501.6bn | at 2024-12-31 | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥401.3bn | at 2023-12-31v | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥362.1bn | at 2022-12-31v | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Cash & equivalents | ¥401.4bn | at 2021-12-31d | Cons. | Cash and cash equivalents US GAAP (5-year summary) |
| Operating cash flow | ¥475.9bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥606.8bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥451.2bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥262.6bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Operating cash flow | ¥451.0bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in operating activities US GAAP (5-year summary) |
| Investing cash flow | −¥237.4bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥297.3bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥275.4bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥180.8bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Investing cash flow | −¥207.3bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in investing activities US GAAP (5-year summary) |
| Financing cash flow | −¥179.2bn | 2025-01-01 → 2025-12-31 | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥226.0bn | 2024-01-01 → 2024-12-31 | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥156.7bn | 2023-01-01 → 2023-12-31v | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥146.8bn | 2022-01-01 → 2022-12-31v | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| Financing cash flow | −¥267.4bn | 2021-01-01 → 2021-12-31d | Cons. | Cash flows from used in financing activities US GAAP (5-year summary) |
| EPS (basic) | ¥367.48 | 2025-01-01 → 2025-12-31 | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥165.53 | 2024-01-01 → 2024-12-31 | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥264.2 | 2023-01-01 → 2023-12-31v | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥236.71 | 2022-01-01 → 2022-12-31v | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (basic) | ¥205.35 | 2021-01-01 → 2021-12-31d | Cons. | Basic earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥367.25 | 2025-01-01 → 2025-12-31 | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥165.44 | 2024-01-01 → 2024-12-31 | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥264.08 | 2023-01-01 → 2023-12-31v | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥236.63 | 2022-01-01 → 2022-12-31v | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| EPS (diluted) | ¥205.29 | 2021-01-01 → 2021-12-31d | Cons. | Diluted earnings loss per share US GAAP (5-year summary) |
| Net assets per share | ¥3,974.81 | at 2025-12-31 | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥3,581.36 | at 2024-12-31 | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥3,394.92 | at 2023-12-31v | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥3,065.97 | at 2022-12-31v | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Net assets per share | ¥2,748.36 | at 2021-12-31d | Cons. | Equity attributable to owners of parent per share US GAAP (5-year summary) |
| Equity ratio | 56.9% | at 2025-12-31 | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 58.6% | at 2024-12-31 | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 61.9% | at 2023-12-31v | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 61.1% | at 2022-12-31v | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| Equity ratio | 60.5% | at 2021-12-31d | Cons. | Equity to asset ratio US GAAP (5-year summary) |
| ROE | 9.7% | 2025-01-01 → 2025-12-31 | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 4.8% | 2024-01-01 → 2024-12-31 | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 8.2% | 2023-01-01 → 2023-12-31v | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 8.1% | 2022-01-01 → 2022-12-31v | Cons. | Rate of return on equity US GAAP (5-year summary) |
| ROE | 7.9% | 2021-01-01 → 2021-12-31d | Cons. | Rate of return on equity US GAAP (5-year summary) |
| Employees | 165,547 | at 2025-12-31 | Cons. | Number of employees |
| Employees | 170,340 | at 2024-12-31 | Cons. | Number of employees |
| Employees | 169,151 | at 2023-12-31v | Cons. | Number of employees |
| Employees | 180,775 | at 2022-12-31v | Cons. | Number of employees |
| Employees | 184,034 | at 2021-12-31d | Cons. | Number of employees |
| Revenue | ¥1.84T | 2025-01-01 → 2025-12-31 | Standalone | Net sales |
| Revenue | ¥1.89T | 2024-01-01 → 2024-12-31 | Standalone | Net sales |
| Revenue | ¥1.67T | 2023-01-01 → 2023-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.74T | 2022-01-01 → 2022-12-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.51T | 2021-01-01 → 2021-12-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥178.2bn | 2025-01-01 → 2025-12-31 | Standalone | Operating income |
| Operating income | ¥220.2bn | 2024-01-01 → 2024-12-31 | Standalone | Operating income |
| Ordinary income | ¥324.3bn | 2025-01-01 → 2025-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥465.5bn | 2024-01-01 → 2024-12-31 | Standalone | Ordinary income |
| Ordinary income | ¥511.6bn | 2023-01-01 → 2023-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥214.3bn | 2022-01-01 → 2022-12-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥248.0bn | 2021-01-01 → 2021-12-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥312.0bn | 2025-01-01 → 2025-12-31 | Standalone | Income before income taxes |
| Profit before tax | ¥524.1bn | 2024-01-01 → 2024-12-31 | Standalone | Income before income taxes |
| Net income | ¥262.1bn | 2025-01-01 → 2025-12-31 | Standalone | Profit loss |
| Net income | ¥469.1bn | 2024-01-01 → 2024-12-31 | Standalone | Profit loss |
| Net income | ¥476.8bn | 2023-01-01 → 2023-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥193.6bn | 2022-01-01 → 2022-12-31v | Standalone | Net income loss (5-year summary) |
| Net income | ¥228.0bn | 2021-01-01 → 2021-12-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥2.98T | at 2025-12-31 | Standalone | Assets |
| Total assets | ¥3.03T | at 2024-12-31 | Standalone | Assets |
| Total assets | ¥2.94T | at 2023-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.91T | at 2022-12-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥2.82T | at 2021-12-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥1.45T | at 2025-12-31 | Standalone | Liabilities |
| Total liabilities | ¥1.31T | at 2024-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.53T | at 2025-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.72T | at 2024-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.59T | at 2023-12-31v | Standalone | Net assets |
| Net assets / equity | ¥1.34T | at 2022-12-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥1.37T | at 2021-12-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥20.5bn | at 2025-12-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥44.7bn | at 2024-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥289.97 | 2025-01-01 → 2025-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥485.14 | 2024-01-01 → 2024-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥476.12 | 2023-01-01 → 2023-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥187.84 | 2022-01-01 → 2022-12-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥218.02 | 2021-01-01 → 2021-12-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥289.79 | 2025-01-01 → 2025-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥484.9 | 2024-01-01 → 2024-12-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥475.92 | 2023-01-01 → 2023-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥187.78 | 2022-01-01 → 2022-12-31v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥217.96 | 2021-01-01 → 2021-12-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥160 | 2025-01-01 → 2025-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥155 | 2024-01-01 → 2024-12-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥140 | 2023-01-01 → 2023-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥120 | 2022-01-01 → 2022-12-31v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥100 | 2021-01-01 → 2021-12-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥1,741.54 | at 2025-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,816.9 | at 2024-12-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,610.54 | at 2023-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,319.84 | at 2022-12-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥1,307.1 | at 2021-12-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 51.3% | at 2025-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.7% | at 2024-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2023-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.0% | at 2022-12-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.5% | at 2021-12-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 16.1% | 2025-01-01 → 2025-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 28.4% | 2024-01-01 → 2024-12-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 32.5% | 2023-01-01 → 2023-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.3% | 2022-01-01 → 2022-12-31v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 17.6% | 2021-01-01 → 2021-12-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 1,333,763,464 | at 2025-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2024-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2023-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2022-12-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,333,763,464 | at 2021-12-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 22,921 | at 2025-12-31 | Standalone | Number of employees |
| Employees | 23,457 | at 2024-12-31 | Standalone | Number of employees |
| Employees | 23,931 | at 2023-12-31v | Standalone | Number of employees |
| Employees | 24,717 | at 2022-12-31v | Standalone | Number of employees |
| Employees | 25,377 | at 2021-12-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 8
| Segment | Item | Period | Value |
|---|---|---|---|
| Imaging Business Unitreportable segment | employees | at 2025-12-31 | 26367 pure |
| Industry Business Unitreportable segment | employees | at 2025-12-31 | 7757 pure |
| Medical Business Unitreportable segment | employees | at 2025-12-31 | 13347 pure |
| Printing Business Unitreportable segment | employees | at 2025-12-31 | 105938 pure |
| Imaging Business Unitreportable segment | employees | at 2025-12-31 | 3899 pure |
| Industry Business Unitreportable segment | employees | at 2025-12-31 | 2558 pure |
| Medical Business Unitreportable segment | employees | at 2025-12-31 | 604 pure |
| Printing Business Unitreportable segment | employees | at 2025-12-31 | 8873 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,502
| Item | Context | Value | Unit |
|---|---|---|---|
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000TanakaYutakaMember | Original text (Japanese)監査役 | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000TanakaYutakaMember | Original text (Japanese)田中 豊 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000TanakaYutakaMember | 1949-03-11 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E02274-000TanakaYutakaMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000TanakaYutakaMember | Original text (Japanese)注４ | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000ShigetomiYukaMember | Original text (Japanese)監査役 | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000ShigetomiYukaMember | Original text (Japanese)重富 由香 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000ShigetomiYukaMember | 1970-06-17 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E02274-000ShigetomiYukaMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000ShigetomiYukaMember | Original text (Japanese)注５ | |
| Official title or position information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000AsakuraKaoriMember | Original text (Japanese)監査役 | |
| Name information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000AsakuraKaoriMember | Original text (Japanese)朝倉 香織 | |
| Date of birth information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000AsakuraKaoriMember | 1968-08-26 | |
| Career summary information about directors and corporate auditors proposal (text) | FilingDateInstant_jpcrp030000-asr_E02274-000AsakuraKaoriMember | Text · Plus | |
| Term of office information about directors and corporate auditors proposal | FilingDateInstant_jpcrp030000-asr_E02274-000AsakuraKaoriMember | Original text (Japanese)注６注８ | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row1Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row2Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row3Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row4Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row5Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row6Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row7Member | Text · Plus | |
| Footnotes directors and corporate auditors proposal (text) | FilingDateInstant_Row8Member | Text · Plus | |
| Footnotes directors and corporate auditors (text) | FilingDateInstant_Row9Member | Text · Plus | |
| Outside directors and outside corporate auditors (text) | FilingDateInstant | Text · Plus | |
| Audits (text) | FilingDateInstant | Text · Plus | |
| Remuneration for directors and other officers (text) | FilingDateInstant | Text · Plus | |
| Remuneration etc paid by group to each director or other officer (text) | FilingDateInstant | Text · Plus | |
| Shareholdings (text) | FilingDateInstant | Text · Plus | |
| Reason for increase in number of shares shares not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Reason for increase in number of shares shares other than those not listed investment shares held for purposes other than pure investment reporting company | CurrentYearDuration | － | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)ルネサスエレクトロニクス(株) | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)半導体露光装置の大口顧客、ならびに半導体サプライヤーとして取引関係の維持・強化等のため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row1Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Median Technologies S.A. | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)メディカル事業における診断/診療ソリューションの販売・提供に係る取引関係の維持・強化等のため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row2Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)トヨタ自動車(株) | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)株主への情報開示、株主総会運営に関する情報収集のため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row3Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)日本電気（株） | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)株主への情報開示、株主総会運営に関する情報収集のため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row4Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)丸紅（株） | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)株主への情報開示、株主総会運営に関する情報収集のため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row5Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)ソニーグループ（株） | |
| Purpose of shareholding overview of business alliance quantitative effects of shareholding and reason for increase in number of shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)株主への情報開示、株主総会運営に関する情報収集のため | |
| Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting company | CurrentYearInstant_Row6Member | Original text (Japanese)無 | |
| Name of securities details of specified investment equity securities held for purposes other than pure investment reporting company | CurrentYearInstant_Row7Member | Original text (Japanese)パナソニックホールディングス（株） |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |